Endocrine & NutritionVideo course2025
Scripps Updates in Diabetes Management 2025 — 20 short talks from the Whittier Diabetes Institute
Scripps Updates in Diabetes Management 2025, from the Scripps Whittier Diabetes Institute on 27 September 2025, packs 20 concise videos into about six hours. Clinicians and researchers cover CGM, automated insulin delivery and remote monitoring, hospital discharge, type 1 adjunct therapy, incretin and SGLT2 drugs across heart, kidney and low-BMI patients, the CATALYST hypercortisolism study, MASH, sexual health, plant protein, adolescents, older adults and weight bias — plus a patient’s view of pump therapy.
- 20videos
- 6hours
- Sep 2025recorded
What you’ll be able to do
- Optimise CGM and automated insulin delivery for diverse patients
- Use GLP-1 RAs and SGLT2i for cardiorenal protection
- Plan safe hospital discharge for people with diabetes
- Individualise targets for adolescents and older adults
- Address sexual health and weight bias in diabetes care
Inside the course
Scripps Updates in Diabetes Management 2025 themes
Technology and remote care, type 1 adjuncts, cardiometabolic drug evidence, hypercortisolism screening, liver disease, nutrition, psychology and ADA 2025 standards for special populations.
Built for
- Primary care physicians, NPs and PAsA fast, current diabetes update.
- Pharmacists, diabetes educators and dietitiansPractical therapy and technology teaching.
Programme
Videos with run times 20 videos
- Testosterone and DHEA in Female Genitourinary Syndrome of Menopause: Indications and Off-Label Approaches — 24:39
- Diabetes Management: How Remote Patient Monitoring and CGM are Reshaping Chronic Care — 05:47
- Remote Patient Monitoring and AI: Addressing Ethical and Legal Concerns in Clinical Care — 19:57
- Diabetes Technology 2025: Optimizing CGM and Automated Insulin Delivery for Diverse Populations — 33:08
- Diabetes Hospital Discharge: Keys to Ensuring Safe Transitions to Home Care — 21:00
- Adjunct Therapies in Type 1 Diabetes: GLP-1 Agonists and SGLT2 Inhibitors—Safety, Efficacy, and Protocols — 12:57
- T1D Patient Perspective: Navigating Insulin Pump Therapy, CGM, and Daily Challenges — 17:31
- CATALYST Study: Should We Routinely Screen for Hypercortisolism in T2D? — 15:41
- Sexual Dysfunction in Diabetes: Testosterone, Genital Anatomy, and Management Approaches — 28:41
- Steatotic Liver Disease (MASH): New Nomenclature, Noninvasive Diagnostics, and 2025 Therapeutic Approvals — 10:39
- GLP-1 and SGLT2 Use in Low BMI Patients: Cardiometabolic and Heart Failure Considerations — 20:17
- GLP-1 Receptor Agonists in Cardiometabolic Disease: Prevention and Management of CVD in 2025 — 17:19
- SGLT2 Inhibitors in T2D and CVD: Landmark Trials and Clinical Recommendations — 25:26
- T2D and CKD: Optimizing Cardiorenal Protection With SGLT2i, GLP-1 RA, and Combination Therapy — 25:22
- GLP1 Receptor Agonists in T2D: Practical Insights on Orals, Injectables, and New Evidence — 13:21
- Plant-Based Protein in T2D: ADA Recommendations for Diabetes Prevention and Management — 17:35
- The Power of Psych: A Tale of 3 Studies — 15:02
- Type 2 Diabetes in Adolescents: 2025 ADA Standards for Screening, Diagnosis, and Management — 15:44
- Geriatric Diabetes: Individualizing A1C Targets and Therapy Selection in Older Adults — 15:43
- Obesity in T2D: New ADA Standards Emphasize Person-First Care and Weight Bias — 07:40
Before you buy
Do I get CME credit or a certificate?
No. Clinicapedia provides the educational content only — no CME or CE credits, MOC points or certificates of completion are included with this product.
Specifications
| Format | Videos |
|---|---|
| Contents | 20 videos · about 6 hours |
| Recorded | 27 September 2025 |
| Publisher | Scripps Health |
| Department | Endocrine & Nutrition |
| Delivery | Instant download · lifetime re-download |


